Abstract:Type I interferons (IFNs) play essential roles in establishing and modulating host defense against microbial infection via induction of IFN-stimulated genes (ISGs) through Janus kinase (JAK)–signal transducer and activator of transcription (STAT) signaling pathway. However, dysregulation of IFNs production and function could also mediate immune pathogenesis such as inflammatory autoimmune diseases and infectious diseases via aberrantly activating inflammatory responses or improperly suppressing microbial controls. Thus, IFN responses need to be tightly regulated to achieve protective immunity against microbial infection while avoiding harmful toxicity caused by improper or prolonged IFN signaling. Multiple levels of cellular and molecular events act in a cooperated manner to regulate IFN responses, in especial, post-translational modification (PTMs) of signaling molecules and epigenetic modification of gene expression programs are two important mechanisms for regulation of IFN signaling and thus critical for orchestrating IFN-mediated host immune response to the complex pathogenic or environmental stimuli. Conventional PTMs such as phosphorylation and polyubiquitylation, as well as numerous other PTMs including acetylation, ISGylation, SUMOylation and methylation have been shown to potently modulate type I IFN signaling transduction via targeting distinct signaling steps or components. Moreover, epigenetic mechanisms, such as histone modification, DNA methylation, non-coding RNAs play critical roles in regulating chromatin structure and function, leading to flexible and dynamic gene expression patterns downstream type I IFN signaling. Herein, we summarize the recent advances in the PTMs and epigenetic mechanisms in regulation of type I IFN signaling and responses. The involvement of dysregulated IFN signaling in inflammatory and autoimmune diseases are also discussed.

Dysregulation of epigenetic modifications in inborn errors of immunity

Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review

Functional genomics in inborn errors of immunity

Bridging the gap: neurodevelopmental disorder risks in inborn errors of immunity

Epigenetic Alterations in Cellular Immunity: New Insights into Autoimmune Diseases

Inborn errors of immunity in adulthood

Inborn errors of immunity underlying defective T-cell memory

Inborn Errors of Immunity and Cytokine Storm Syndromes

Gene regulation in inborn errors of immunity: Implications for gene therapy design and efficacy

Enrichment of Immune Dysregulation Disorders in Adult Patients with Human Inborn Errors of Immunity

Epigenetic Regulation of B Cells and Its Role in Autoimmune Pathogenesis

Gut Microbiota–Host Interactions in Inborn Errors of Immunity

Inborn Errors of Immunity and Their Phenocopies: CTLA4 and PD-1

Learning from inborn errors

Immunodysregulation in immunodeficiency

Epigenetic regulation of innate immune dynamics during inflammation

Epigenetic regulation of innate lymphoid cells

JAK/STAT defects and immune dysregulation, and guiding therapeutic choices

Treg in inborn errors of immunity: gaps, knowns and future perspectives

Type 2 T-Helper Cell Driven Manifestations of Inborn Errors of Immunity

Genetic and epigenetic dysregulation of innate immune mechanisms in autoinflammatory diseases